Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03057158 · ClinicalTrials.gov registry record
Genomics and Epigenomics for New Insights in fEmale OAB (GENIE) Study
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 257
- Enrollment target
NCT03057158 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 257 participants.
The verdict
NCT03057158 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 257 participants
- Enrollment target
Study Summary
Millions of women suffer from overactive bladder, and the changes in bladder function affect their quality of life. The study team believes that it needs to be better understand why women get overactive bladder in the first place so that better treatments can eventually be offered. The purpose of this study is to determine why women with insulin resistance are more likely to get overactive bladder. Overactive bladder is a type of bladder control problem that can cause some women to have bladder leakage. This problem is more common in women with diabetes and pre-diabetes, but it isn't known why.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2017-05-01 |
| Est. Completion | 2020-03-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03057158
The ClinicalTrials.gov registry entry for NCT03057158 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 257 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT03057158 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03057158 about?
NCT03057158 is a clinical study titled "Genomics and Epigenomics for New Insights in fEmale OAB (GENIE) Study". Millions of women suffer from overactive bladder, and the changes in bladder function affect their quality of life. The study team believes that it needs to be better understand why women get overactive bladder in the first place so that better treatments can eventually be offered. The purpose of t...
What is the current status of trial NCT03057158?
This trial is currently completed. The enrollment target is 257 participants. The study started on 2017-05-01. Estimated completion is 2020-03-11.
Who is sponsoring clinical trial NCT03057158?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.